Search - Archive ouverte HAL Access content directly

Filter your results

26 Results
authFullName_s : I. Jariel-Encontre

Ubiquitin-Independent Proteasomal Degradation of Fra-1 Is Antagonized by Erk1/2 Pathway-Mediated Phosphorylation of a Unique C-Terminal Destabilizer

J. Basbous , D. Chalbos , R. Hipskind , I. Jariel-Encontre , Marc Piechaczyk et al.
Molecular and Cellular Biology, 2007, 27 (11), pp.3936-3950. ⟨10.1128/MCB.01776-06⟩
Journal articles hal-02376617v1

Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL

A. E. Sayan , R. Stanford , R. Vickery , E. Grigorenko , J. Diesch et al.
Oncogene, 2012, 31 (12), pp.1493--503. ⟨10.1038/onc.2011.336⟩
Journal articles hal-02193074v1

Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity

C. Barette , I. Jariel-Encontre , Marc Piechaczyk , J. Piette
Oncogene, 2001, 20 (5), pp.551--62. ⟨10.1038/sj.onc.1204129⟩
Journal articles hal-02197302v1
Image document

Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer

G. Moquet-Torcy , C. Tolza , Marc Piechaczyk , I. Jariel-Encontre
Nucleic Acids Research, 2014, 42 (17), pp.11011-11024. ⟨10.1093/nar/gku814⟩
Journal articles hal-02191584v1

The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers

M. Pariat , C. Salvat , M. Bebien , F. Brockly , E. Altieri et al.
Biochemical Journal, 2000, 345 Pt 1, pp.129--38. ⟨10.1042/bj3450129⟩
Journal articles hal-02196826v1

Cellular and viral Fos proteins are degraded by different proteolytic systems

C. Acquaviva , C. Salvat , F. Brockly , G. Bossis , P. Ferrara et al.
Oncogene, 2001, 20 (8), pp.942--50. ⟨10.1038/sj.onc.1204155⟩
Journal articles hal-02197300v1

JunB Breakdown in Mid-/Late G2 Is Required for Down-Regulation of Cyclin A2 Levels and Proper Mitosis

R. Farras , Véronique Baldin , S. Gallach , C. Acquaviva , G. Bossis et al.
Molecular and Cellular Biology, 2008, 28 (12), pp.4173-4187. ⟨10.1128/MCB.01620-07⟩
Journal articles hal-02353388v1

Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy?

R. Farras , G. Bossis , E. Andermarcher , I. Jariel-Encontre , Marc Piechaczyk et al.
Critical Reviews in Oncology/Hematology, 2005, 54 (1), pp.31--51. ⟨10.1016/j.critrevonc.2004.11.004⟩
Journal articles istex hal-02262226v1
Image document

Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome

I. Jariel-Encontre , M. Pariat , F. Martin , S. Carillo , C. Salvat et al.
Journal of Biological Chemistry, 1995, 270 (19), pp.11623-11627. ⟨10.1074/jbc.270.19.11623⟩
Journal articles hal-02192665v1

Multiple degradation pathways for Fos family proteins

C. Acquaviva , G. Bossis , P. Ferrara , F. Brockly , I. Jariel-Encontre et al.
Annals of the New York Academy of Sciences, 2002, 973, pp.426--34. ⟨10.1111/j.1749-6632.2002.tb04677.x⟩
Journal articles istex hal-02197484v1

Rôle du système ubiquitine-protéasome dans le contrôle du cycle cellulaire. Dérégulation dans les cancers.

I. Jariel-Encontre , R. Farras
Coux, O. Protéasome, ubiquitine et protéines apparentées à l'ubiquitine, Lavoisier, 2010
Book sections hal-02193577v1

c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo

G. Bossis , P. Ferrara , C. Acquaviva , I. Jariel-Encontre , Marc Piechaczyk et al.
Molecular and Cellular Biology, 2003, 23 (20), pp.7425--36. ⟨10.1128/MCB.23.20.7425-7436.2003⟩
Journal articles hal-02199821v1

Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20 - Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo

C. Salvat , C. Acquaviva , M. Scheffner , I. Robbins , Marc Piechaczyk et al.
European Journal of Biochemistry, 2000, 267 (12), pp.3712--3722. ⟨10.1046/j.1432-1327.2000.01404.x⟩
Journal articles hal-02196854v1

Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation

G. Bossis , C. E. Malnou , R. Farras , E. Andermarcher , R. Hipskind et al.
Molecular and Cellular Biology, 2005, 25 (16), pp.6964--79. ⟨10.1128/MCB.25.16.6964-6979.2005⟩
Journal articles hal-02262225v1

Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses

C. Acquaviva , G. Bossis , P. Ferrara , F. Brockly , I. Jariel-Encontre et al.
Biochemical Pharmacology, 2002, 64 (5-6), pp.957--61. ⟨10.1016/s0006-2952(02)01159-0⟩
Journal articles istex hal-02197483v1

Protéolyse protéasomale indépendante de l'ubiquitylation des susbtrats

I. Jariel-Encontre , G. Bossis , Marc Piechaczyk
Coux, O. Protéasome, ubiquitine et protéines apparentées à l'ubiliquitine, Lavoisier, 2010
Book sections hal-02193576v1

Complex mechanisms for c-fos and c-jun degradation

I. Jariel-Encontre , C. Salvat , A. M. Steff , M. Pariat , C. Acquaviva et al.
Molecular Biology Reports, 1997, 24 (1-2), pp.51--6. ⟨10.1023/A:1006804723722⟩
Journal articles istex hal-02194298v1

The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression

P. Ferrara , E. Andermarcher , G. Bossis , C. Acquaviva , F. Brockly et al.
Oncogene, 2003, 22 (10), pp.1461--1474. ⟨10.1038/sj.onc.1206266⟩
Journal articles hal-02239689v1

Degradation of cellular and viral Fos proteins

C. Acquaviva , P. Ferrara , G. Bossis , F. Brockly , C. Salvat et al.
Biochimie, 2001, 83 (3-4), pp.357--62. ⟨10.1016/S0300-9084(01)01243-3⟩
Journal articles istex hal-02197299v1

PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein

S. Carillo , M. Pariat , A. Steff , I. Jariel-Encontre , F. Poulat et al.
Biochemical Journal, 1996, 313 ( Pt 1), pp.245--51. ⟨10.1042/bj3130245⟩
Journal articles hal-02194118v1

Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts

C. Salvat , I. Jariel-Encontre , C. Acquaviva , S. Omura , Marc Piechaczyk et al.
Oncogene, 1998, 17 (3), pp.327--37. ⟨10.1038/sj.onc.1201922⟩
Journal articles hal-02195936v1
Image document

SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1

S. Salinas , A. Briancon-Marjollet , G. Bossis , M. A. Lopez , Marc Piechaczyk et al.
Journal of Cell Biology, 2004, 165 (6), pp.767--73. ⟨10.1083/jcb.200310136⟩
Journal articles hal-02262387v1

[Proteasomal degradation: from addressing of substrates to therapeutical perspectives]

E. Andermarcher , G. Bossis , R. Farras , I. Jariel-Encontre , Marc Piechaczyk et al.
médecine/sciences, 2005, 21 (2), pp.141--9. ⟨10.1051/medsci/2005212141⟩
Journal articles hal-02262221v1

Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein

F. Talotta , T. Mega , G. Bossis , L. Casalino , J. Basbous et al.
Oncogene, 2010, 29 (33), pp.4732--40. ⟨10.1038/onc.2010.211⟩
Journal articles hal-02193625v1

Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition

C. Acquaviva , F. Brockly , P. Ferrara , G. Bossis , C. Salvat et al.
Oncogene, 2001, 20 (51), pp.7563--72. ⟨10.1038/sj.onc.1204880⟩
Journal articles hal-02197298v1

Intracellular proteolysis and tumorigenesis

P. Ferrara , C. Acquaviva , G. Bossis , Marc Piechaczyk , I. Jariel-Encontre et al.
médecine/sciences, 2001, 17 (1), pp.5--13. ⟨10.4267/10608/1782⟩
Journal articles hal-02197455v1